Metastatic Liposarcoma

Also known as: Liposarcoma metastatic

DrugDrug NameDrug Description
DB08871EribulinA microtubule inhibitor used to treat metastatic breast cancer and metastatic or unresectable liposarcoma.
DB05109TrabectedinAn alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma).
DrugDrug NamePhaseStatusCount
DB00997Doxorubicin1Active Not Recruiting1
DB11730Ribociclib1Active Not Recruiting1
DB11945Avelumab1 / 2Active Not Recruiting1
DB05109Trabectedin1 / 2Active Not Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB06589Pazopanib2Active Not Recruiting1
DB01030Topotecan2Active Not Recruiting1